Literature DB >> 25346935

Tubal origin of ovarian low-grade serous carcinoma.

Chenglu Chen1, Jie Li2, Guang Yao3, Setsuko K Chambers4, Wenxin Zheng5.   

Abstract

Entities:  

Year:  2013        PMID: 25346935      PMCID: PMC4205570     

Source DB:  PubMed          Journal:  Am J Clin Exp Obstet Gynecol        ISSN: 2330-1899


× No keyword cloud information.
  48 in total

1.  Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.

Authors:  David W Kindelberger; Yonghee Lee; Alexander Miron; Michelle S Hirsch; Colleen Feltmate; Fabiola Medeiros; Michael J Callahan; Elizabeth O Garner; Robert W Gordon; Chandler Birch; Ross S Berkowitz; Michael G Muto; Christopher P Crum
Journal:  Am J Surg Pathol       Date:  2007-02       Impact factor: 6.394

Review 2.  The role of the fallopian tube in the origin of ovarian cancer.

Authors:  Britt K Erickson; Michael G Conner; Charles N Landen
Journal:  Am J Obstet Gynecol       Date:  2013-04-10       Impact factor: 8.661

3.  Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.

Authors:  J D Seidman; R J Kurman
Journal:  Am J Surg Pathol       Date:  1996-11       Impact factor: 6.394

Review 4.  Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm.

Authors:  Robert J Kurman; Ie-Ming Shih
Journal:  Hum Pathol       Date:  2011-07       Impact factor: 3.466

Review 5.  Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis.

Authors:  W Glenn McCluggage
Journal:  Pathology       Date:  2011-08       Impact factor: 5.306

6.  In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential.

Authors:  C J Haas; J Diebold; A Hirschmann; H Rohrbach; U Löhrs
Journal:  Virchows Arch       Date:  1999-02       Impact factor: 4.064

Review 7.  New insights into the pathogenesis of serous ovarian cancer and its clinical impact.

Authors:  Keren Levanon; Christopher Crum; Ronny Drapkin
Journal:  J Clin Oncol       Date:  2008-10-14       Impact factor: 44.544

8.  Serous borderline (low malignant potential, atypical proliferative) ovarian tumors: workshop perspectives.

Authors:  Debra A Bell; Teri A Longacre; Jaime Prat; Elise C Kohn; Robert A Soslow; Lora H Ellenson; Anais Malpica; Mark H Stoler; Robert J Kurman
Journal:  Hum Pathol       Date:  2004-08       Impact factor: 3.466

9.  Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images.

Authors:  Jeffrey D Seidman; Robert A Soslow; Russell Vang; Jules J Berman; Mark H Stoler; Mark E Sherman; Esther Oliva; Andre Kajdacsy-Balla; David M Berman; Larry J Copeland
Journal:  Hum Pathol       Date:  2004-08       Impact factor: 3.466

10.  Serous carcinogenesis in the fallopian tube: a descriptive classification.

Authors:  Elke Jarboe; Ann Folkins; Marisa R Nucci; David Kindelberger; Ronny Drapkin; Alexander Miron; Yonghee Lee; Christopher P Crum
Journal:  Int J Gynecol Pathol       Date:  2008-01       Impact factor: 2.762

View more
  3 in total

1.  Cytologic studies of in vivo fallopian tube specimens in patients undergoing salpingo-oophorectomy.

Authors:  Sharmila Pramanik; Eric Yang; Wendy Wu
Journal:  Cytojournal       Date:  2020-08-10       Impact factor: 2.091

2.  BRCA1 expression, proliferative and apoptotic activities in ovarian epithelial inclusions.

Authors:  Yiying Wang; Yue Wang; Li Wei; Shuhui Hong; Miaoqing Zhao; Xi Zhang; Wenxin Zheng
Journal:  J Ovarian Res       Date:  2017-03-07       Impact factor: 4.234

3.  IMP3 signatures of fallopian tube: a risk for pelvic serous cancers.

Authors:  Yiying Wang; Yue Wang; Dake Li; Lingmin Li; Wenjing Zhang; Guang Yao; Zhong Jiang; Wenxin Zheng
Journal:  J Hematol Oncol       Date:  2014-07-12       Impact factor: 17.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.